Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

Between 2018 and 2024, China has launched 188 domestically developed innovative drugs – nearly double the number from the ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

Health experts say popular weight-loss drugs like Ozempic and Wegovy are safe, but the FDA warns counterfeits are becoming more widespread.

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

Popular weight-loss therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Influencer and podcast maven Claudia Oshry used Ozempic to kickstart a newfound wellness journey.

Regeneron (NASDAQ: REGN) is testing its drug, trevogrumab, along with Wegovy and another treatment, garetosmab, in a ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...